Discover 524 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 524
Critical Delays in Cardiopulmonary Resuscitation During Simulated Obstetric Crisis: a Prospective Observational Study.
for
Maternal Death During Childbirth
Location: Calgary
Sponsor: KidSIM Simulation Program
Sex: All
Age: 18+
Code: NCT04050631
Recruiting
Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain
for
Neuropathic Pain
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT00850005
Phase2, Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
for
Facioscapulohumeral Muscular Dystrophy, FSHD,
Location: Calgary, Edmonton, Ottawa, Montreal
Sponsor: Avidity Biosciences, Inc.
Sex: All
Age: 16 - 70
Code: NCT07038200
Phase3, Recruiting
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Get alerts for new trials in your area by subscribing now
Study of Atomoxetine in the Prevention of Vasovagal Syncope
for
Vasovagal Syncope
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT05159687
Phase3, Recruiting
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
for
Vasovagal Syncope (VVS), Syncope
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 70+
Code: NCT05755737
Phase2, Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Calgary, Rapid City SD, Riverton UT, Las Vegas NV,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase2, Recruiting
Airway Remodeling and Rhinovirus in Asthmatics
for
Asthma, Respiratory Disease
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 65
Code: NCT05775952
Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
for
Heart Failure
Location: Calgary, Edmonton, Surrey, North Vancouver, Victoria,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06033950
Phase3, Recruiting
Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial
for
Syncope
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 50 - 70+
Code: NCT05776810
Recruiting
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
for
Obstructive Sleep Apnea of Adult, Hypoxia, Brain, Sleep Apnea,
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 45
Code: NCT03255408
Phase1, Phase2, Recruiting
Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome
for
Patellofemoral Pain Syndrome
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 45
Code: NCT02613247
Phase2, Recruiting
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
for
Neurogenic Detrusor Overactivity
Location: Calgary, Aurora CO, Wichita KS, Oklahoma City OK,
Sponsor: Urovant Sciences GmbH
Sex: All
Age: 2 - 17
Code: NCT05491525
Phase2, Phase3, Recruiting
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
for
Juvenile Idiopathic Arthritis
Location: Calgary
Sponsor: Sanofi
Sex: All
Age: 1 - 17
Code: NCT02991469
Phase2, Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for
Pulmonary Arterial Hypertension (PAH),
Location: Calgary, Bend OR, Aurora CO, Rancho Cordova CA,